Business Context and Reporting Period
This Form 8-K filing by AnaptysBio, Inc. (Nasdaq: ANAB) reports on the outcomes of the Company's 2021 Annual Meeting of Stockholders held on June 17, 2021. The filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance report regarding stockholder votes and does not contain financial performance data.
Material Changes and Voting Results
The following proposals were adopted by the stockholders:
- Election of Directors: Three Class I directors were elected to three-year terms expiring at the 2024 Annual Meeting:
- Dennis Fenton, Ph.D.: 18,114,189 shares For; 2,677,584 shares Withheld/Abstaining.
- James Topper, M.D., Ph.D.: 18,036,482 shares For; 2,755,291 shares Withheld/Abstaining.
- Oleg Nodelman: 20,772,618 shares For; 19,155 shares Withheld/Abstaining.
- Ratification of Auditors: KPMG LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2021.
- Votes: 23,645,851 For; 14,613 Against; 10,761 Withheld/Abstaining.
- Executive Compensation: Non-binding, advisory approval of compensation for named executive officers was granted.
- Votes: 20,696,275 For; 91,221 Against; 4,277 Withheld/Abstaining.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the reporting of voting results.
Investor Verification Checklist
- Verify the tenure and background of the newly elected directors (Fenton, Topper, Nodelman) and their specific roles on the Board.
- Confirm the engagement letter terms with KPMG LLP for the 2021 fiscal year.
- Review the Company's most recent 10-K or 10-Q filings for actual financial performance metrics, as this 8-K contains none.
- Check for any subsequent filings regarding the implementation of the advisory compensation vote.